Healthcare ❯Pharmaceuticals ❯Drug Development

Oncology Drugs

Opdivo Darzalex

Johnson & Johnson Exceeds Q4 Expectations with Strong Cancer Drug Sales

Bristol Myers Squibb Surges on Strong Q2 Performance and Raised Guidance